Herceptin plus taxol highly effective in lower-risk breast cancer patients
A remarkable 98.7 percent of certain lower-risk breast cancer patients were cancer free for at least three years after taking a combination of the drugs Herceptin and Taxol, a study has found.
Dec 11, 2013
0
0